Brand Engagement Network Inc. shares surged 32.56% in pre-market trading, reaching a 52-week high.
The company has finalized a strategic partnership with Valio Technologies, securing $2.05 million in funding to establish an exclusive AI licensing framework aimed at government and commercial markets in Africa. This partnership is expected to enhance Brand Engagement Network's competitive position and drive growth in the rapidly expanding digital economy of Africa, particularly through a mental health initiative in collaboration with Nelson Mandela University.
This significant financial backing and strategic alliance position Brand Engagement Network for long-term success in the AI sector, addressing critical needs in mental health support while capitalizing on the growing demand for AI solutions.
Brand Engagement Network Inc. is a generative artificial intelligence (AI) (GenAI) company specialized in conversational AI solutions. Through its human-like AI agents (AI Agents), available in different modalities, it seeks to transform consumer engagement and elevate customer experience, productivity, and business performance. Its AI assistants are built on proprietary natural language processing, anomaly detection, multisensory awareness, sentiment and environmental analysis, as well as real-time individuation and personalization capabilities. Its platform is designed to configure, train and operate AI assistants that engage with professionals and consumers through multiple channels, boosting customer experience and providing instant personalized assistance for consumers in the automotive and healthcare markets. Its AI Agents can be offered to its clients’ customers through mobile apps, desktops or laptops, as well as through in-store life-size kiosks and SDK integrations.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
